Neuroleptic interaction with the serotoninergic-dopaminergic mechanisms in the nucleus accumbens.
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D003533:Cyproheptadine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004347:Drug Interactions; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009714:Nucleus Accumbens / Q000187:drug effects*; D051381:Rats; D012686:Septal Nuclei / Q000187:drug effects*; D012701:Serotonin / Q000502:physiology*
D014150:Antipsychotic Agents; D003533:Cyproheptadine; D012701:Serotonin; D004298:Dopamine; D008784:Methysergide